Medication adherence is a complex issue, and Lonny Reisman, MD, CEO of HealthReveal, emphasized the importance of better understanding what methods or strategies will help motivate patients to do what is in their best interest.
Medication adherence is a complex issue, and Lonny Reisman, MD, CEO of HealthReveal, emphasized the importance of better understanding what methods or strategies will help motivate patients to do what is in their best interest.
Transcript (slightly modified)
How can big data help with improving medication adherence?
So the issue of medication adherence is complex. There could be cost issues. There could be side-effect issues. There can be issues around a relative lack of symptoms associated with certain diseases. Basically, even poor glycemic control at certain levels won’t create symptoms. So the issue is as we identify patients who are adherent or we test hypothesis regarding what would drive incentives to take medicines, we will be able to learn what would work across poor populations.
One of the issues I’ve been involved with, or at least when I was at Aetna, was value-based insurance design where we would lower or eliminate co-pays for certain essential therapeutics for certain patients. And although we saw increases in adherence when drugs were given say for free, we actually rarely saw improvements over 50% adherence. So to the extent that people who have had serious diseases won’t even take their medicines for free, it underscores the importance of understanding better how we can motivate people to do what ultimately is in their best interest.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More